Viewing Study NCT06000657


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2025-12-26 @ 9:36 PM
Study NCT ID: NCT06000657
Status: COMPLETED
Last Update Posted: 2025-03-18
First Post: 2023-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module